Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
In April MF Invested In IT, Pharma And Telecom
In the absence of earnings growth triggers, which has shrunk the universe of investible ideas, leading fund houses have resorted to selling more of a part of their portfolios than…
Sun Pharma Dropped In Market After Us Lawsuit
Share prices of some leading domestic pharmaceutical companies, led by Sun Pharmaceutical Industries, fell 4-9 per cent on Monday, after being named in a price-fixing lawsuit in the US. The…
Large pharma companies increase prices ofgeneric drugs by up to one thousand percent
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on…
The Supreme Court arrived against the nomination rejection PS Chatwal will keep its favour
Torak Pharmaceutical company managing director PS Chatwal has now appealed to the Supreme Court against the rejection of the nomination. Chatwal said that the election commission has also been in…
Medlife acquires Myra, to expand medicine delivery service
Medlife, which operates an online pharmacy and healthcare platform, has acquired Bengaluru’s medicine delivery startup Myra Medicines. The deal will help Medlife scale Myra’s express delivery service across its own…
NPPA fixes retail prices of 22 formulations under DPCO, 2013
Name of the formulations are mesalazine sachet, clotrimazole+ beclomethasone+ neomycin cream, telmisartan +cilnidipine+ chlorthalidone tablet, paracetamol +phenylephrine+caffeine (Anhydrous)+ diphenhydramine tablet, methylcobalamin+ pyridoxine + folic acid tablet, medoxomil + amlodipine +…
Biocon Bets Fired On Biosimilar For Revenue Growth
Searing growth in its biosimilar business is expected to help see Biocon cross $1 billion in revenue this fiscal. Biosimilars, or biologics, are biological drugs that are developed to be…
Price War In Anti Diabetic Medicine Segment
A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…
Many essential drugs priced much higher than manufacturing cost: WHO
NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows…
